Managing the coagulopathy associated with cardiopulmonary bypass

Machin, 2006, Principles of cardiopulmonary bypass, Cont Educ in Anaesth Crit Care Pain, 6, 176, 10.1093/bjaceaccp/mkl043 Barry, 2015, Anesthetic management during cardiopulmonary bypass: a systematic review, Anest Analg, 120, 749, 10.1213/ANE.0000000000000612 Dyke, 2014, Universal definition of perioperative bleeding in adult cardiac surgery, J Thorac Cardiovasc Surg, 147:, 1458, 10.1016/j.jtcvs.2013.10.070 Erdoes, 2019, The role of fibrinogen and fibrinogen concentrate in cardiac surgery: an international consensus statement from the Haemostasis and Transfusion Scientific Subcommittee of the European Association of Cardiothoracic Anaesthesiology, Anaesthesia, 74, 1589, 10.1111/anae.14842 Bartoszko, 2018, Comparison of Two Major Perioperative Bleeding Scores for Cardiac Surgery Trials: Universal Definition of Perioperative Bleeding in Cardiac Surgery and European Coronary Artery Bypass Grafting Bleeding Severity Grade, Anesthesiology, 129, 1092, 10.1097/ALN.0000000000002179 Brouwers, 2017, Benchmarking the use of blood products in cardiac surgery to stimulate awareness of transfusion behaviour: Results from a four‐year longitudinal study, Neth Heart J, 25, 207, 10.1007/s12471-016-0936-1 Bennett‐Guerrero, 2010, Variation in use of blood transfusion in coronary artery bypass graft surgery, JAMA, 304, 1568, 10.1001/jama.2010.1406 Spahn, 2019, The European guideline on management of major bleeding and coagulopathy following trauma: fifth edition, Crit Care, 23, 98, 10.1186/s13054-019-2347-3 Faraoni, 2014, Van der Linden P. Plasma fibrinogen concentration is correlated with postoperative blood loss in children undergoing cardiac surgery. A retrospective review, Eur J Anaesthesiol, 31, 317, 10.1097/EJA.0000000000000043 Karkouti, 2004, The independent association of massive blood loss with mortality in cardiac surgery, Transfusion, 44, 1453, 10.1111/j.1537-2995.2004.04144.x Karkouti, 2013, The relationship between fibrinogen levels after cardiopulmonary bypass and large volume red cell transfusion in cardiac surgery: an observational study, Anest Analg, 117, 14, 10.1213/ANE.0b013e318292efa4 Brouwers, 2017, Benchmarking the use of blood products in cardiac surgery to stimulate awareness of transfusion behaviour : Results from a four‐year longitudinal study, Neth Heart J, 25, 207, 10.1007/s12471-016-0936-1 Koster, 2002, Hemostatic Activation and Inflammatory Response during Cardiopulmonary Bypass: Impact of Heparin Management, Anesthesiology, 97, 837, 10.1097/00000542-200210000-00014 Ranucci, 2017, Hemodilution on Cardiopulmonary Bypass: Thromboelastography Patterns and Coagulation‐Related Outcomes, J Cardiothorac Vasc Anesth, 31, 1588, 10.1053/j.jvca.2017.04.014 Hofer, 2016, A Snapshot of Coagulopathy After Cardiopulmonary Bypass, Clin Appl Thromb Hemost, 22, 505, 10.1177/1076029616651146 Hall, 1997, The Systemic Inflammatory Response to Cardiopulmonary Bypass: Pathophysiological, Therapeutic, and Pharmacological Considerations, Anest Analg, 85, 766, 10.1213/00000539-199710000-00011 Baumann Kreuziger, 2018, Antithrombotic therapy management of adult and pediatric cardiac surgery patients, J Thromb Haemost, 16, 2133, 10.1111/jth.14276 Coakley, 2011, Assessment of thrombin generation measured before and after cardiopulmonary bypass surgery and its association with postoperative bleeding, J Thromb Haemost, 9, 282, 10.1111/j.1538-7836.2010.04146.x Wong, 2011, Thrombography reveals thrombin generation potential continues to deteriorate following cardiopulmonary bypass surgery despite adequate hemostasis, J Extra Corpor Technol, 43, 19, 10.1051/ject/201143019 Kjellberg, 2020, Platelet function analysed by ROTEM platelet in cardiac surgery after cardiopulmonary bypass and platelet transfusion, Transf Med, 30, 369, 10.1111/tme.12678 Ho, 2019, The association between platelet dysfunction and adverse outcomes in cardiac surgical patients, Anaesthesia, 74, 1130, 10.1111/anae.14631 Karkouti, 2018, Preventing and managing catastrophic bleeding during extracorporeal circulation, Hematology Am Soc Hematol Educ Program, 2018, 522, 10.1182/asheducation-2018.1.522 Biancari, 2018, Meta‐analysis of the Sources of Bleeding after Adult Cardiac Surgery, J Cardiothorac Vasc Anesth, 32, 1618, 10.1053/j.jvca.2017.12.024 Meesters, 2019, Optimizing Perioperative Blood and Coagulation Management During Cardiac Surgery, Anesthesiol Clin, 37, 713, 10.1016/j.anclin.2019.08.006 Cholette, 2018, Patient Blood Management in Pediatric Cardiac Surgery: A Review, Anest Analg, 127, 1002, 10.1213/ANE.0000000000002504 Faraoni, 2019, Use of antifibrinolytics in pediatric cardiac surgery: Where are we now?, Pediat Anesth, 29, 435, 10.1111/pan.13533 Bartoszko, 2017, Can predicting transfusion in cardiac surgery help patients?, Br J Anaesth, 119, 350, 10.1093/bja/aex216 Klein, 2017, The ACTA PORT‐score for predicting perioperative risk of blood transfusion for adult cardiac surgery, Br J Anaesth, 119, 394, 10.1093/bja/aex205 Kwak, 2018, Heart Transplantation in an Era of Mechanical Circulatory Support, J Cardiothorac Vasc Anesth, 32, 19, 10.1053/j.jvca.2017.09.042 Ferraris, 2007, Perioperative blood transfusion and blood conservation in cardiac surgery: the Society of Thoracic Surgeons and The Society of Cardiovascular Anesthesiologists clinical practice guideline, Ann Thorac Surg, 83, S27, 10.1016/j.athoracsur.2007.02.099 Kozek‐Langenecker, 2017, Management of severe perioperative bleeding: guidelines from the European Society of Anaesthesiology: First update 2016, Eur J Anaesthesiol, 34, 332, 10.1097/EJA.0000000000000630 Sousa‐Uva, 2014, Surgery ESCWGoC, Thrombosis ESCWGo. Expert position paper on the management of antiplatelet therapy in patients undergoing coronary artery bypass graft surgery, Eur Heart J, 35, 1510, 10.1093/eurheartj/ehu158 Levine, 2016, Circulation, 134, 123, 10.1161/CIR.0000000000000404 Sousa‐Uva, 2018, 2017 EACTS Guidelines on perioperative medication in adult cardiac surgery, Eur J Cardiothorac Surg, 53, 5, 10.1093/ejcts/ezx314 Shore‐Lesserson, 2018, STS/SCA/AmSECT Clinical Practice Guidelines: Anticoagulation during Cardiopulmonary Bypass, J Extra Corpor Technol, 50, 5, 10.1051/ject/201850005 Boer, 2018, 2017 EACTS/EACTA Guidelines on patient blood management for adult cardiac surgery, J Cardiothorac Vasc Anesth, 32, 88, 10.1053/j.jvca.2017.06.026 Raval Amish, 2017, Management of Patients on Non‐Vitamin K Antagonist Oral Anticoagulants in the Acute Care and Periprocedural Setting: A Scientific Statement From the American Heart Association, Circulation, 135, 604 Macle, 2016, 2016 Focused Update of the Canadian Cardiovascular Society Guidelines for the Management of Atrial Fibrillation, Can J Cardiol, 32, 1170, 10.1016/j.cjca.2016.07.591 Steffel, 2018, The 2018 European Heart Rhythm Association Practical Guide on the use of non‐vitamin K antagonist oral anticoagulants in patients with atrial fibrillation, Eur Heart J, 39, 1330, 10.1093/eurheartj/ehy136 Sato, 2015, Accelerated activation of the coagulation pathway during cardiopulmonary bypass in aortic replacement surgery: a prospective observational study, J Cardiothorac Surg, 10, 84, 10.1186/s13019-015-0295-9 Slaughter, 1994, Characterization of prothrombin activation during cardiac surgery by hemostatic molecular markers, Anesthesiology, 80, 520, 10.1097/00000542-199403000-00007 Hirsh, 2001, Guide to Anticoagulant Therapy: Heparin, Circulation, 103, 2994, 10.1161/01.CIR.103.24.2994 Boisclair, 1993, Mechanisms of thrombin generation during surgery and cardiopulmonary bypass, Blood, 82, 3350, 10.1182/blood.V82.11.3350.3350 Horton, 2013, Activated clotting time (ACT), Methods Mol Biol, 992, 155, 10.1007/978-1-62703-339-8_12 Dirkmann, 2019, Point‐of‐care measurement of activated clotting time for cardiac surgery as measured by the Hemochron signature elite and the Abbott i‐STAT: agreement, concordance, and clinical reliability, BMC Anesthesiol, 19, 174, 10.1186/s12871-019-0846-z Welsby, 2002, Activated Clotting Time Systems Vary In Precision And Bias And Are Not Interchangeable When Following Heparin Management Protocols During Cardiopulmonary Bypass, J Clin Monit Comput, 17, 287, 10.1023/A:1021298103264 Paniccia, 2003, Evaluation of a new point‐of‐care celite‐activated clotting time analyzer in different clinical settings. The i‐STAT celite‐activated clotting time test, Anesthesiology, 99, 54, 10.1097/00000542-200307000-00012 Boer, 2018, Anticoagulant and side‐effects of protamine in cardiac surgery: a narrative review, Br J Anaesth, 120, 914, 10.1016/j.bja.2018.01.023 Welsby, 2005, Hemodynamic Changes after Protamine Administration: Association with Mortality after Coronary Artery Bypass Surgery, Anesthesiology, 102, 308, 10.1097/00000542-200502000-00011 Kunz, 2018, The effect of protamine dosing variation on bleeding and transfusion after heparinisation for cardiopulmonary bypass, Perfusion, 33, 445, 10.1177/0267659118763043 Falter, 2018, Clinical Evaluation of Measuring the ACT during Elective Cardiac Surgery with Two Different Devices, J Extra Corpor Technol, 50, 38, 10.1051/ject/201850038 Jeong, 2017, Does Activated Clotting Time Help to Predict Innate Coagulopathy in End‐Stage Liver Disease Patients?, Transpl Proc, 49, 1076, 10.1016/j.transproceed.2017.03.042 Abuelkasem, 2019, Clinical Impact of Protamine Titration‐Based Heparin Neutralization in Patients Undergoing Coronary Bypass Grafting Surgery, J Cardiothorac Vasc Anesth, 33, 2153, 10.1053/j.jvca.2019.01.026 Fujii, 2013, Hepcon HMS Plus® reduced intraoperative protamine dosages following weaning from cardiopulmonary bypass: 6AP3‐7, Euro J Anaesthesiol, 30, 99, 10.1097/00003643-201306001-00308 Garvin, 2010, Heparin concentration‐based anticoagulation for cardiac surgery fails to reliably predict heparin bolus dose requirements, Anest Analg, 111, 849, 10.1213/ANE.0b013e3181b79d09 Ichikawa, 2017, Changes in heparin dose response slope during cardiac surgery: possible result in inaccuracy in predicting heparin bolus dose requirement to achieve target ACT, Perfusion, 32, 474, 10.1177/0267659117692661 Radulovic, 2015, Heparin and Protamine Titration Does Not Improve Haemostasis after Cardiac Surgery: A Prospective Randomized Study, PLoS One, 10, 10.1371/journal.pone.0130271 Lemmer, 2002, Antithrombin III concentrate to treat heparin resistance in patients undergoing cardiac surgery, J Thorac Cardiovasc Surg, 123, 213, 10.1067/mtc.2002.119060 Panicucci, 1980, Antithrombin III, heparin cofactor and antifactor Xa in relation to age, sex and pathological condition, Haemostasis, 9, 297 Raphael, 2019, Society of Cardiovascular Anesthesiologists Clinical Practice Improvement Advisory for Management of Perioperative Bleeding and Hemostasis in Cardiac Surgery Patients, Anest Analg, 129, 1209, 10.1213/ANE.0000000000004355 Hashimoto, 1994, Heparin and antithrombin III levels during cardiopulmonary bypass: correlation with subclinical plasma coagulation, Ann Thorac Surg, 58, 799, 10.1016/0003-4975(94)90752-8 Koster, 2015, Antifibrinolytic Therapy for Cardiac Surgery: An Update, Anesthesiology, 123, 214, 10.1097/ALN.0000000000000688 Guo, 2019, Different dose regimes and administration methods of tranexamic acid in cardiac surgery: a meta‐analysis of randomized trials, BMC Anesthesiol, 19, 129, 10.1186/s12871-019-0772-0 Jerath, 2018, Tranexamic Acid Dosing for Cardiac Surgical Patients With Chronic Renal Dysfunction: A New Dosing Regimen, Anest Analg, 127, 1323, 10.1213/ANE.0000000000002724 2019, disability, vascular occlusive events and other morbidities in patients with acute traumatic brain injury (CRASH‐3): a randomised, placebo‐controlled trial, Lancet, 394, 1713, 10.1016/S0140-6736(19)32233-0 Myles, 2016, Tranexamic Acid in Patients Undergoing Coronary‐Artery Surgery, N Engl J Med, 376, 136, 10.1056/NEJMoa1606424 Esper, 2011, Intra‐operative cell salvage: a fresh look at the indications and contraindications, Blood Transfus, 9, 139 Carless, 2010, Cell salvage for minimising perioperative allogeneic blood transfusion, Cochrane Database Syst Rev, 4, Cd001888 Niranjan, 2006, Effects of cell saver autologous blood transfusion on blood loss and homologous blood transfusion requirements in patients undergoing cardiac surgery on‐ versus off‐cardiopulmonary bypass: a randomised trial, Eur J Cardiothorac Surg, 30, 271, 10.1016/j.ejcts.2006.04.042 Son, 2020, Effects of Cardiac Surgery and Salvaged Blood Transfusion on Coagulation Function Assessed by Thromboelastometry, J Cardiothorac Vasc Anesth, 34, 2375, 10.1053/j.jvca.2020.02.009 Canver, 1995, The effects of intraoperative autologous whole blood sequestration on the need for transfusion of allogenic blood and blood products in coronary bypass operations, J Cardiovasc Surg (Torino), 36, 423 Stover, 2000, Platelet‐rich plasma sequestration, with therapeutic platelet yields, reduces allogeneic transfusion in complex cardiac surgery, Anest Analg, 90, 509, 10.1097/00000539-200003000-00002 Hofmann, 2018, Positive impact of retrograde autologous priming in adult patients undergoing cardiac surgery: a randomized clinical trial, J Cardiothorac Surg, 13, 50, 10.1186/s13019-018-0739-0 Palanzo, 2005, Perfusion safety: defining the problem, Perfusion, 20, 195, 10.1191/0267659105pf806oa Zhou, 2015, Autologous Platelet‐Rich Plasma Reduces Transfusions During Ascending Aortic Arch Repair: A Prospective, Randomized, Controlled Trial, Ann Thorac Surg, 99, 1282, 10.1016/j.athoracsur.2014.11.007 Wajon, 2001, Intraoperative Plateletpheresis and Autologous Platelet Gel Do Not Reduce Chest Tube Drainage or Allogeneic Blood Transfusion After Reoperative Coronary Artery Bypass Graft, Anest Analg, 93, 536, 10.1097/00000539-200109000-00004 Nishi, 2019, The incidence and risk factors of hypofibrinogenemia in cardiovascular surgery, Gen Thorac Cardiovasc Surg, 68, 335, 10.1007/s11748-019-01201-8 Ortmann, 2015, Validation of viscoelastic coagulation tests during cardiopulmonary bypass, J Thromb Haemost, 13, 1207, 10.1111/jth.12988 Nelson, 1994, Rapid preparation of plasma for 'Stat' coagulation testing, Arch Pathol Lab Med, 118, 175 Pappas, 1991, Rapid preparation of plasma for coagulation testing, Arch Pathol Lab Med, 115, 816 Mazer, 2017, Restrictive or Liberal Red‐Cell Transfusion for Cardiac Surgery, N Engl J Med, 377, 2133, 10.1056/NEJMoa1711818 Karkouti, 2016, Point‐of‐Care Hemostatic Testing in Cardiac Surgery: A Stepped‐Wedge Clustered Randomized Controlled Trial, Circulation, 134, 1152, 10.1161/CIRCULATIONAHA.116.023956 Schmidt, 2019, Correlation of thromboelastography and thrombin generation assays in warfarin‐treated patients, Thromb Res, 178, 34, 10.1016/j.thromres.2019.03.022 Schmidt, 2019, The Utility of Thromboelastography to Guide Blood Product Transfusion: An ACLPS Critical Review, Am J Clin Pathol, 152, 407, 10.1093/ajcp/aqz074 Srivastava, 2012, Point‐of‐care coagulation testing, Cont Educ Anaesth Crit Care Pain, 13, 12, 10.1093/bjaceaccp/mks049 Lloyd‐Donald, 2020, Assessing TEG6S reliability between devices and across multiple time points: A prospective thromboelastography validation study, Sci Rep, 10, 7045, 10.1038/s41598-020-63964-y Schenk, 2019, A comparison of the new ROTEM®sigma with its predecessor, the ROTEMdelta, Anaesthesia, 74, 348, 10.1111/anae.14542 Lloyd‐Donald, 2019, Assessment of agreement and interchangeability between the TEG5000 and TEG6S thromboelastography haemostasis analysers: a prospective validation study, BMC Anesthesiol, 19, 45, 10.1186/s12871-019-0717-7 2017 Gertler, 2011, Are the Point‐of‐Care Diagnostics MULTIPLATE and ROTEM Valid in the Setting of High Concentrations of Heparin and Its Reversal With Protamine?, J Cardiothorac Vasc Anesth, 25, 981, 10.1053/j.jvca.2010.11.020 Whiting, 2014, TEG and ROTEM: technology and clinical applications, Am J Hematol, 89, 228, 10.1002/ajh.23599 Substantial Equivalence Determination Decision Memorandum. In: Hematology, ed., 2015, 1‐18. Corporation H. TEG 5000 Hemostasis Analyzer System: The new standard of care in hemostasis management. Switzerland: European Headquarters, Haemonetics S.A., 2010, 7. Brunner NE. CORA (Coagulation Resonance Analysis) System In: System MFIVCS, ed. Niles, Illinois: Coramed Technologies LLC, 2015. Ferrante, 2016, A Novel Device for the Evaluation of Hemostatic Function in Critical Care Settings, Anest Analg, 123, 1372, 10.1213/ANE.0000000000001413 Baryshnikova, 2019, A Comparative Study of SEER Sonorheometry Versus Standard Coagulation Tests, Rotational Thromboelastometry, and Multiple Electrode Aggregometry in Cardiac Surgery, J Cardiothorac Vasc Anesth, 33, 1590, 10.1053/j.jvca.2019.01.011 Zghaibe, 2020, Clinical utility of the Quantra® point‐of‐care haemostasis analyser during urgent cardiac surgery, Anaesthesia, 75, 366, 10.1111/anae.14942 Groves, 2020, Multicenter Evaluation of the Quantra QPlus System in Adult Patients Undergoing Major Surgical Procedures, Anest Analg, 130, 899, 10.1213/ANE.0000000000004659 Ranucci, 2020, Sensitivity of Viscoelastic Tests to Platelet Function, J Clin Med, 9, 189, 10.3390/jcm9010189 Orlov, 2014, Platelet dysfunction as measured by a point‐of‐care monitor is an independent predictor of high blood loss in cardiac surgery, Anest Analg, 118, 257, 10.1213/ANE.0000000000000054 Monroe, 2002, Platelets and Thrombin Generation, Arterioscler Thromb Vasc Biol, 22, 1381, 10.1161/01.ATV.0000031340.68494.34 Van Poucke, 2016, Early platelet recovery following cardiac surgery with cardiopulmonary bypass, Platelets, 27, 751, 10.3109/09537104.2016.1173665 Mahla, 2018, Is There a Role for Preoperative Platelet Function Testing in Patients Undergoing Cardiac Surgery During Antiplatelet Therapy?, Circulation, 138, 2145, 10.1161/CIRCULATIONAHA.118.035160 Paniccia, 2015, Platelet function tests: a comparative review, Vasc Health Risk Manag, 11, 133, 10.2147/VHRM.S44469 Lang, 2005, Multi‐centre investigation on reference ranges for ROTEM thromboelastometry, Blood Coagul Fibrinolysis, 16, 301, 10.1097/01.mbc.0000169225.31173.19 Callum, 2019, Effect of Fibrinogen Concentrate vs Cryoprecipitate on Blood Component Transfusion After Cardiac Surgery: The FIBRES Randomized Clinical Trial, JAMA, 322, 1, 10.1001/jama.2019.17312 Levy, 2015, How I use fibrinogen replacement therapy in acquired bleeding, Blood, 125, 1387, 10.1182/blood-2014-08-552000 Kalantari, 2013, Assessment of intravascular volume status and volume responsiveness in critically ill patients, Kidney Int, 83, 1017, 10.1038/ki.2012.424 Ranucci, 2013, Major bleeding, transfusions, and anemia: the deadly triad of cardiac surgery, Ann Thorac Surg, 96, 478, 10.1016/j.athoracsur.2013.03.015 Hajjar, 2013, High lactate levels are predictors of major complications after cardiac surgery, J Thorac Cardiovasc Surg, 146, 455, 10.1016/j.jtcvs.2013.02.003 Rundgren, 2008, A Thromboelastometric Evaluation of the Effects of Hypothermia on the Coagulation System, Anest Analg, 107, 8, 10.1213/ane.0b013e31817ee955 Cantle, 2017, Balanced Resuscitation in Trauma Management, Surg Clin North Am, 97, 999, 10.1016/j.suc.2017.06.002 Holcomb, 2015, Mortality and ratio of blood products used in patients with severe trauma–reply, JAMA, 313, 2078, 10.1001/jama.2015.4427 Holcomb, 2015, Transfusion of plasma, platelets, and red blood cells in a 1:1:1 vs a 1:1:2 ratio and mortality in patients with severe trauma: the PROPPR randomized clinical trial, JAMA, 313, 471, 10.1001/jama.2015.12 Delaney, 2017, Massive Transfusion in Cardiac Surgery: The Impact of Blood Component Ratios on Clinical Outcomes and Survival, Anest Analg, 124, 12, 10.1213/ANE.0000000000001926 Wiesenack, 2005, Assessment of fluid responsiveness in mechanically ventilated cardiac surgical patients, Eur J Anaesthesiol, 22, 658, 10.1017/S0265021505001092 Arora, 2016, Recent trends on hemodynamic monitoring in cardiac surgery, Ann Card Anaesth, 19, 580, 10.4103/0971-9784.191557 Woodman, 1990, Bleeding complications associated with cardiopulmonary bypass, Blood, 76, 1680, 10.1182/blood.V76.9.1680.1680 Hall, 2001, Re‐exploration for hemorrhage following open heart surgery differentiation on the causes of bleeding and the impact on patient outcomes, Ann Thorac Cardiovasc Surg, 7, 352 Dacey, 1998, Group ftNNECDS. Reexploration for Hemorrhage Following Coronary Artery Bypass Grafting: Incidence and Risk Factors, Arch Surg, 133, 442, 10.1001/archsurg.133.4.442 Karthik, 2004, Reexploration for bleeding after coronary artery bypass surgery: risk factors, outcomes, and the effect of time delay, Ann Thorac Surg, 78, 527, 10.1016/j.athoracsur.2004.02.088 Tripodi, 2016, Thrombin Generation Assay and Its Application in the Clinical Laboratory, Clin Chem, 62, 699, 10.1373/clinchem.2015.248625 Duarte, 2017, Thrombin generation assays for global evaluation of the hemostatic system: perspectives and limitations, Rev Bras Hematol Hemoter, 39, 259, 10.1016/j.bjhh.2017.03.009 Bosch, 2013, Preoperative thrombin generation is predictive for the risk of blood loss after cardiac surgery: a research article, J Cardiothorac Surg, 8, 154, 10.1186/1749-8090-8-154 Fitzgerald, 2020, Thrombin generation and bleeding in cardiac surgery: a clinical narrative review, Can J Anaesth, 67, 746, 10.1007/s12630-020-01609-4 Liu, 2017, Consumption coagulopathy in acute aortic dissection: principles of management, J Cardiothorac Surg, 12, 50, 10.1186/s13019-017-0613-5 Müller, 2019, Thromboelastometry in critically ill patients with disseminated intravascular coagulation, Blood Coagul Fibrinolysis, 30, 181, 10.1097/MBC.0000000000000808 Ghadimi, 2016, Perioperative management of the bleeding patient, BJA, 117, iii18, 10.1093/bja/aew358 Roman, 2019, Prothrombin Complex Concentrate in Cardiac Surgery: A Systematic Review and Meta‐Analysis, Ann Thorac Surg, 107, 1275, 10.1016/j.athoracsur.2018.10.013 Fitzgerald, 2018, Use of prothrombin complex concentrate for management of coagulopathy after cardiac surgery: a propensity score matched comparison to plasma, Br J Anaesth, 120, 928, 10.1016/j.bja.2018.02.017 Tanaka, 2013, Perioperative factor concentrate therapy, BJA, 111, i35, 10.1093/bja/aet380 Gill, 2009, Safety and efficacy of recombinant activated factor VII: a randomized placebo‐controlled trial in the setting of bleeding after cardiac surgery, Circulation, 120, 21, 10.1161/CIRCULATIONAHA.108.834275 Karkouti, 2008, Comprehensive Canadian review of the off‐label use of recombinant activated factor VII in cardiac surgery, Circulation, 118, 331, 10.1161/CIRCULATIONAHA.108.764308 Dunkley, 2008, Recombinant activated factor VII in cardiac surgery: experience from the Australian and New Zealand Haemostasis Registry, Ann Thorac Surg, 85, 836, 10.1016/j.athoracsur.2007.06.076 Ekert, 2006, Blood Coagul Fibrinolysis, 17, 389, 10.1097/01.mbc.0000233369.03358.c1 Ganter, 2008, Monitoring Recombinant Factor VIIa Treatment: Efficacy Depends on High Levels of Fibrinogen in a Model of Severe Dilutional Coagulopathy, J Cardiothorac Vasc Anesth, 22, 675, 10.1053/j.jvca.2008.01.017 Hoffmann, 2018, A role for very low‐dose recombinant activated factor VII in refractory bleeding after cardiac surgery: Lessons from an observational study, J Thorac Cardiovasc Surg, 156, 1564, 10.1016/j.jtcvs.2018.03.167 Brase, 2016, Analysis of Outcomes Using Low‐Dose and Early Administration of Recombinant Activated Factor VII in Cardiac Surgery, Ann Thorac Surg, 102, 35, 10.1016/j.athoracsur.2016.01.004 PRODUCT MONOGRAPHNiaStase RT® eptacog alfa (activated) Activated Recombinant Human Blood Coagulation Factor VII Room Temperature Stable. In: Inc. NNC, ed., October 18, 2018 edn, 2018. Rao, 2014, Factor VIII Inhibitor Bypass Activity and Recombinant Activated Factor VII in Cardiac Surgery, J Cardiothorac Vasc Anesth, 28, 1221, 10.1053/j.jvca.2014.04.015 Balsam, 2008, Factor Eight Inhibitor Bypassing Activity (FEIBA) for Refractory Bleeding in Cardiac Surgery: Review of Clinical Outcomes, J Card Surg, 23, 614, 10.1111/j.1540-8191.2008.00686.x Weber, 2010, A point‐of‐care assessment of the effects of desmopressin on impaired platelet function using multiple electrode whole‐blood aggregometry in patients after cardiac surgery, Anest Analg, 110, 702, 10.1213/ANE.0b013e3181c92a5c Wademan, 2014, Desmopressin for reducing postoperative blood loss and transfusion requirements following cardiac surgery in adults, Interact Cardiovasc Thorac Surg, 18, 360, 10.1093/icvts/ivt491 Crescenzi, 2008, Desmopressin reduces transfusion needs after surgery: a meta‐analysis of randomized clinical trials, Anesthesiology, 109, 1063, 10.1097/ALN.0b013e31818db18b Desborough MJ, Oakland K, Brierley C, et al. Desmopressin use for minimising perioperative blood transfusion. Cochrane Database of Systematic Reviews. 2017. https://doi.org/10.1002/14651858.CD001884.pub3 Cattaneo, 2008, The use of desmopressin in open‐heart surgery, Haemophilia : the official journal of the World Federation of Hemophilia, 14, 40, 10.1111/j.1365-2516.2007.01608.x Connolly, 2019, Full Study Report of Andexanet Alfa for Bleeding Associated with Factor Xa Inhibitors, N Engl J Med, 380, 1326, 10.1056/NEJMoa1814051 Mujer, 2020, An Update on the Reversal of Non‐Vitamin K Antagonist Oral Anticoagulants, Adv Hematol, 2020, 7636104, 10.1155/2020/7636104 Cuker, 2014, Laboratory Measurement of the Anticoagulant Activity of the Non‐Vitamin K Oral Anticoagulants, J Am Coll Cardiol, 64, 1128, 10.1016/j.jacc.2014.05.065 Kobayashi, 2018, Laboratory measures of coagulation among trauma patients on NOAs: results of the AAST‐MIT, Trauma Surg Acute Care Open, 3, 10.1136/tsaco-2018-000231 Henskens, 2018, Detecting clinically relevant rivaroxaban or dabigatran levels by routine coagulation tests or thromboelastography in a cohort of patients with atrial fibrillation, Thrombos J, 16, 3, 10.1186/s12959-017-0160-2 Paikin, 2010, New antithrombotic agents–insights from clinical trials, Nat Rev Cardiol, 7, 498, 10.1038/nrcardio.2010.101 Geisler B, Liao J, Manian F.Replacing warfarin with a NOAC in patients on chronic anticoagulation therapy: Hospitalists must consider clinical factors and patient preferences. The Hospitalist August 22, 2018 edn: The Society of Hospital Medicine 2018.